Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aimi Zafira Razman"'
Autor:
Johanes Dedi Kanchau, Ralph Kwame Akyea, Noorhida Baharudin, Mohamed-Syarif Mohamed-Yassin, Aisyah Kamal, Yung-An Chua, Aimi Zafira Razman, Hasidah Abdul-Hamid, Suraya Abdul-Razak, Siti Fatimah Badlishah-Sham, Aznida Firzah Abdul Aziz, Nadeem Qureshi, Anis Safura Ramli
Publikováno v:
Clinical Epidemiology and Global Health, Vol 27, Iss , Pp 101619- (2024)
Background: Adults with severely elevated low-density lipoprotein cholesterol (LDL-c) may have familial hypercholesterolaemia (FH) and are at high risk of atherosclerotic cardiovascular disease (ASCVD). The prevalence of elevated LDL-c in primary car
Externí odkaz:
https://doaj.org/article/2c5ccf0eb9064363847b9cb3e9ee6bda
Autor:
Aimi Zafira Razman, Noorhida Baharudin, Noor Alicezah Mohd Kasim, Alyaa Al-Khateeb, Zaliha Ismail, Hapizah Nawawi
Publikováno v:
Healthcare; Volume 10; Issue 12; Pages: 2448
Dyslipidaemia is a major cause of morbidity and mortality. The aims of this study are to determine the prevalence of dyslipidaemia subtypes, the proportions of lipid-lowering therapy (LLT) use, and the achievement of low-density lipoprotein cholester
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc08c9ab78075e8dd9b11aad33d53db5
https://pubmed.ncbi.nlm.nih.gov/36553972
https://pubmed.ncbi.nlm.nih.gov/36553972
Publikováno v:
Journal of Atherosclerosis and Thrombosis
Aim: Familial hypercholesterolaemia (FH) is the most common autosomal dominant lipid disorder, leading to severe hypercholesterolaemia. Early detection and treatment with lipid-lowering medications may reduce the risk of premature coronary artery dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb97755a9b95d4443efd1624544bc6b
http://europepmc.org/articles/PMC8560842
http://europepmc.org/articles/PMC8560842
Autor:
Aimi Zafira Razman, Yung-An Chua, Noor Alicezah Mohd Kasim, Alyaa Al-Khateeb, Siti Hamimah Sheikh Abdul Kadir, Siti Azma Jusoh, Hapizah Nawawi
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 23; Pages: 14971
Familial hypercholesterolaemia (FH) is caused by mutations in lipid metabolism genes, predominantly in low-density lipoprotein receptor (LDLR), apolipoprotein B (APOB), proprotein convertase subtilisin/kexin-type 9 (PCSK9) and LDL receptor adaptor pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05251c8fed8c2042d1e92867a9b9738f
https://doi.org/10.3390/ijms232314971
https://doi.org/10.3390/ijms232314971